Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results episode artwork

EPISODE · Nov 19, 2024 · 3 MIN

Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

from Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM · host Annenberg Center for Health Sciences

Author: Nicolle M, et al.Overview Provided by Nicolas Silvestri, MD

Episode metadata supplied by the publisher feed · Published Nov 19, 2024

Embed this episode

Ready to play

Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

0:00 3:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM?

This episode is 3 minutes long.

When was this Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM episode published?

This episode was published on November 19, 2024.

Can I download this Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!